Journal article
Targeted molecular therapeutics for Parkinson's Disease: A role for antisense oligonucleotides?
Movement Disorders, Vol.37(11), pp.2184-2190
2022
Abstract
Parkinson's disease (PD) is a prevalent neurodegenerative disorder characterized by marked heterogeneity in clinical symptoms and a complex genetic background...
Details
- Title
- Targeted molecular therapeutics for Parkinson's Disease: A role for antisense oligonucleotides?
- Authors/Creators
- D. Li (Author/Creator) - Perron Institute for Neurological and Translational ScienceF.L. Mastaglia (Author/Creator) - Perron Institute for Neurological and Translational ScienceW.Y. Yau (Author/Creator) - Perron Institute for Neurological and Translational ScienceS. Chen (Author/Creator) - Ruijin HospitalS.D. Wilton (Author/Creator) - Perron Institute for Neurological and Translational ScienceP.A. Akkari (Author/Creator)
- Publication Details
- Movement Disorders, Vol.37(11), pp.2184-2190
- Publisher
- Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
- Identifiers
- 991005542160807891
- Copyright
- © 2022 The Authors.
- Murdoch Affiliation
- Centre for Molecular Medicine and Innovative Therapeutics
- Language
- English
- Resource Type
- Journal article
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
Source: InCites
Metrics
41 File views/ downloads
156 Record Views
InCites Highlights
These are selected metrics from InCites Benchmarking & Analytics tool, related to this output
- Collaboration types
- Domestic collaboration
- International collaboration
- Citation topics
- 1 Clinical & Life Sciences
- 1.52 Neurodegenerative Diseases
- 1.52.67 Parkinson's Disease
- Web Of Science research areas
- Clinical Neurology
- ESI research areas
- Neuroscience & Behavior